Healthcare & Medical Equipment Suppliers Sector Financials, Performance and Ratios
-
Sector Score
38.9 /100
Rank 11 out of 27 Sectors -
Advance/Decline
146/73
-
No. of Companies219
-
Avg. Market Cap9,289
-
Price to Earning Ratio32.24
-
Price to Earning Growth Ratio12.84
-
Price to Book Ratio33.51
-
Return on Equity36.43
-
Return on Capital Employed-
-
Return on Assets5.84
-
Dividend yield 1 year %0.20 %
-
Net Profit Growth Annual YoY %-2.35 %
-
Net Profit Growth Qtr YoY %28.47 %
-
Net Profit Growth Qtr QoQ %7.69 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare & Medical Equipment Suppliers Sector Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare & Medical Equipment Suppliers Peer comparison
Compare all stocks in Healthcare & Medical Equipment Suppliers industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
41,387.2
|
146.8
|
L
 -0.1%
H
144.7
148.5
|
L
 -2.7%
H
141.3
149.2
|
L
 -1.7%
H
141.3
163.8
|
L
 13.1%
H
123.7
163.8
|
L
 19.1%
H
108.4
163.8
|
L
 29.4%
H
96.4
163.8
|
L
 -14.7%
H
96.4
177.4
|
L
 226.9%
H
42.9
179.6
|
| Amerisource Bergen Corp |
|
-
|
326.2
|
L
 1.5%
H
322.5
327.8
|
L
 -1.4%
H
318.0
330
|
L
 5.4%
H
302.0
338.7
|
L
 15.8%
H
269.3
338.7
|
L
 7.8%
H
244.8
377.5
|
L
 12.4%
H
244.8
377.5
|
L
 163.9%
H
113.7
377.5
|
L
 282.7%
H
68.4
377.5
|
| Abbott |
|
178,385.2
|
103.1
|
L
 1.1%
H
102.6
104.4
|
L
 -4.8%
H
101.5
108.4
|
L
 -7.4%
H
101.5
117.3
|
L
 16.9%
H
87.2
117.3
|
L
 -22.9%
H
82.0
137.5
|
L
 0.4%
H
82.0
141.2
|
L
 -18.6%
H
82.0
142.6
|
L
 153.7%
H
37.4
142.6
|
| Alcon Inc - Registered Shares |
|
32,745.5
|
67.7
|
L
 2.6%
H
66.6
67.8
|
L
 -3.9%
H
65.9
69.6
|
L
 -7.9%
H
65.9
74.9
|
L
 1.3%
H
63.8
76.2
|
L
 -13.5%
H
61.8
87.6
|
L
 -16.6%
H
61.8
101.1
|
L
 -19.3%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
1,217.4
|
25.0
|
L
 -0.4%
H
24.8
25.7
|
L
 -2.4%
H
24.4
25.8
|
L
 -12.1%
H
24.4
30.1
|
L
 24.2%
H
19.9
30.1
|
L
 -38.7%
H
19.2
48.3
|
L
 62.9%
H
12.2
48.3
|
L
 0.2%
H
9.6
48.3
|
L
 45.4%
H
9.6
48.3
|
| Avantor Inc |
|
10,253.6
|
15.2
|
L
 2.4%
H
14.7
15.2
|
L
 1.3%
H
14.6
15.5
|
L
 9.5%
H
13.3
15.5
|
L
 61.5%
H
9.2
15.5
|
L
 23.2%
H
7.3
15.9
|
L
 -29.0%
H
7.3
28
|
L
 -64.2%
H
7.3
44.4
|
L
H
6.7
44.4
|
| Baxter International |
|
12,335.5
|
23.9
|
L
 0.3%
H
23.6
24.2
|
L
 -7.6%
H
23.6
25.8
|
L
 -11.8%
H
23.6
27.2
|
L
 14.4%
H
19.4
30
|
L
 -0.5%
H
15.7
30
|
L
 -39.0%
H
15.7
44
|
L
 -70.4%
H
15.7
89.7
|
L
 -47.4%
H
15.7
95.2
|
| Becton, Dickinson and Co. |
|
49,822.3
|
182.9
|
L
 2.9%
H
179.6
183.5
|
L
 -1.0%
H
175.2
183.5
|
L
 0.5%
H
175.2
193.1
|
L
 25.1%
H
140.1
193.1
|
L
 -2.1%
H
140.1
213.1
|
L
 -31.0%
H
140.1
269.5
|
L
 -27.5%
H
140.1
287.3
|
L
 9.6%
H
140.1
287.3
|
| Butterfly Network Inc (Class A) |
|
1,973.2
|
7.4
|
L
 1.1%
H
7.3
7.5
|
L
 0.7%
H
7.1
7.8
|
L
 -16.4%
H
7.1
9.7
|
L
 33.8%
H
5.4
10.1
|
L
 372.0%
H
1.6
10.1
|
L
 325.9%
H
0.7
10.1
|
L
 -41.2%
H
0.7
13.2
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
9,854.4
|
368.6
|
L
 -0.2%
H
365.7
370.5
|
L
 -4.6%
H
365.7
390.7
|
L
 2.0%
H
351.8
396.2
|
L
 28.9%
H
270
396.2
|
L
 31.5%
H
236.7
396.2
|
L
 0.0%
H
211.4
396.2
|
L
 -53.5%
H
211.4
811.7
|
L
 134.9%
H
154.9
832.7
|
| Bausch + Lomb Corp |
|
6,279.0
|
17.6
|
L
 1.9%
H
17.3
17.7
|
L
 -2.6%
H
17.0
18.2
|
L
 3.5%
H
16.8
18.5
|
L
 16.6%
H
14.7
18.5
|
L
 15.7%
H
13.8
18.9
|
L
 -0.5%
H
10.5
21.7
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Boston Scientific |
|
65,287.8
|
45.1
|
L
 4.8%
H
43.9
45.2
|
L
 -5.8%
H
42.8
47.5
|
L
 -12.9%
H
42.8
53.0
|
L
 -4.0%
H
42.2
53.0
|
L
 -56.1%
H
42.2
105.7
|
L
 -15.3%
H
42.2
109.5
|
L
 1.9%
H
35.0
109.5
|
L
 93.7%
H
19.7
109.5
|
| Cardinal Health |
|
54,629.7
|
234.9
|
L
 0.1%
H
232.6
237.6
|
L
 -5.0%
H
232.6
245.8
|
L
 1.6%
H
227.7
249.3
|
L
 4.9%
H
219.5
258.3
|
L
 54.3%
H
145.9
258.3
|
L
 167.1%
H
85.8
258.3
|
L
 343.6%
H
45.9
258.3
|
L
 200.8%
H
39.1
258.3
|
| Conmed Corp |
|
1,389.1
|
46.4
|
L
 0.2%
H
46.2
47.3
|
L
 -6.0%
H
45.9
49.1
|
L
 -6.9%
H
45.9
52.5
|
L
 33.4%
H
31.4
53.7
|
L
 -12.0%
H
31.4
53.7
|
L
 -56.8%
H
31.4
117.3
|
L
 -62.3%
H
31.4
159.1
|
L
 17.7%
H
31.4
159.1
|
| Cooper Companies |
|
10,310.2
|
54.2
|
L
 0.6%
H
53.6
55.0
|
L
 -22.1%
H
51.0
69.0
|
L
 -29.2%
H
51.0
78.1
|
L
 -20.1%
H
51.0
78.1
|
L
 -18.7%
H
51.0
89.8
|
L
 -37.1%
H
51.0
112.4
|
L
 -50.8%
H
51.0
112.4
|
L
 16.7%
H
39.7
115.9
|
| Danaher |
|
142,881.9
|
203.3
|
L
 1.6%
H
199.1
203.8
|
L
 -2.1%
H
199.1
207.8
|
L
 -0.3%
H
199.1
220.7
|
L
 12.9%
H
165.8
220.7
|
L
 7.0%
H
160.9
242.8
|
L
 -19.5%
H
160.9
281.7
|
L
 -36.8%
H
160.9
331.7
|
L
 164.4%
H
75.7
334.0
|
| Enovis Corp |
|
1,050.7
|
18.2
|
L
 -5.5%
H
18
19.7
|
L
 -1.8%
H
18
20.2
|
L
 -29.0%
H
18
27.5
|
L
 -16.4%
H
18
31.7
|
L
 -42.6%
H
18
34.3
|
L
 -65.9%
H
18
65.0
|
L
H
18
72.1
|
L
H
18
72.1
|
| Edwards Lifesciences |
|
49,293.7
|
85.5
|
L
 1.4%
H
85.1
86.3
|
L
 -4.9%
H
83.8
89.1
|
L
 -7.6%
H
83.8
93.3
|
L
 0.5%
H
81.2
96.3
|
L
 10.3%
H
72.3
96.3
|
L
 16.9%
H
58.9
96.3
|
L
 -28.3%
H
58.9
131.7
|
L
 124.6%
H
27.0
131.7
|
| Glaukos Corp |
|
10,091.6
|
171.1
|
L
 2.3%
H
165.4
171.4
|
L
 -3.6%
H
165.4
185.4
|
L
 -9.7%
H
165.4
191.6
|
L
 34.9%
H
125.4
191.6
|
L
 106.7%
H
73.2
191.6
|
L
 124.8%
H
59.2
191.6
|
L
 240.5%
H
33.3
191.6
|
L
 401.1%
H
23.1
191.6
|
| Globus Medical Inc (Class A) |
|
10,173.0
|
75.8
|
L
 2.1%
H
74.7
76.9
|
L
 -3.2%
H
72.8
78.3
|
L
 -11.8%
H
72.8
88.9
|
L
 -5.8%
H
72.8
88.9
|
L
 29.0%
H
54.2
101.4
|
L
 54.3%
H
43.4
101.4
|
L
 -6.0%
H
43.4
101.4
|
L
 234.5%
H
19.3
101.4
|
| Haemonetics Corp |
|
4,836.8
|
106.3
|
L
 3.5%
H
102.8
107.5
|
L
 3.3%
H
100.5
107.5
|
L
 17.6%
H
89.1
109.6
|
L
 36.0%
H
71.8
109.6
|
L
 103.7%
H
47.3
109.6
|
L
 18.6%
H
47.3
109.6
|
L
 56.3%
H
43.5
109.6
|
L
 193.9%
H
32.8
142.1
|
| Inspire Medical Systems Inc |
|
2,148.6
|
74.3
|
L
 1.8%
H
71.8
75.3
|
L
 17.8%
H
61.6
75.3
|
L
 27.7%
H
55.4
75.3
|
L
 74.1%
H
39.7
75.3
|
L
 -7.2%
H
38.9
147.0
|
L
 -65.9%
H
38.9
257.4
|
L
 -68.3%
H
38.9
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
4,287.4
|
126.1
|
L
 0.1%
H
126.1
126.3
|
L
 -0.3%
H
125.9
126.5
|
L
 0.9%
H
124.8
126.8
|
L
 38.6%
H
87.0
126.8
|
L
 24.5%
H
62
126.8
|
L
 55.4%
H
62
146.4
|
L
 35.1%
H
50.1
146.4
|
L
 447.2%
H
18.1
146.4
|
| McKesson |
|
106,208.0
|
911.0
|
L
 3.3%
H
893.4
912
|
L
 0.3%
H
874.3
912
|
L
 6.3%
H
837.9
930.0
|
L
 16.2%
H
744.5
930.0
|
L
 28.1%
H
687.7
999
|
L
 116.6%
H
418.0
999
|
L
 342.1%
H
193.9
999
|
L
 418.1%
H
106.1
999
|
| Medtronic |
|
119,983.1
|
93.8
|
L
 3.1%
H
92.7
94.1
|
L
 -0.4%
H
90.3
94.1
|
L
 3.6%
H
89.9
95.4
|
L
 17.0%
H
77.6
95.4
|
L
 -0.2%
H
73.3
106.3
|
L
 15.3%
H
68.9
106.3
|
L
 -27.9%
H
68.9
132.6
|
L
 10.6%
H
68.9
135.9
|
| Mettler-Toledo International |
|
25,762.0
|
1,285.8
|
L
 -0.6%
H
1274.5
1306.1
|
L
 -4.4%
H
1266.6
1347.9
|
L
 -10.1%
H
1266.6
1456.8
|
L
 13.6%
H
1121.1
1474.2
|
L
 2.1%
H
1023.1
1525.2
|
L
 14.1%
H
928.5
1546.9
|
L
 -17.3%
H
928.5
1714.8
|
L
 225.8%
H
393.8
1714.8
|
| Envista Holdings Corp |
|
4,142.3
|
25.8
|
L
 0.9%
H
25.3
25.9
|
L
 -5.5%
H
25.2
27.4
|
L
 -8.2%
H
25.2
28.9
|
L
 4.8%
H
24.5
29
|
L
 22.8%
H
18.8
30.4
|
L
 -12.4%
H
14.2
30.4
|
L
 -40.6%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
86.1
|
1.1
|
L
 3.7%
H
1.0
1.1
|
L
 -7.4%
H
1.0
1.2
|
L
 1.8%
H
0.9
1.4
|
L
 -66.4%
H
0.9
3.8
|
L
 -79.0%
H
0.9
5.7
|
L
 -93.1%
H
0.9
28.4
|
L
 -96.9%
H
0.9
49.1
|
L
 -96.7%
H
0.9
49.2
|
| Penumbra Inc |
|
12,599.1
|
319.9
|
L
 0.7%
H
318.7
320.3
|
L
 -0.7%
H
317.6
322.6
|
L
 -2.1%
H
317.6
328.6
|
L
 0.4%
H
314.8
328.6
|
L
 17.3%
H
221.3
362.4
|
L
 14.5%
H
148
362.4
|
L
 14.5%
H
114.9
362.4
|
L
 359.9%
H
56.1
362.4
|
| Perkinelmer Inc |
|
-
|
128.5
|
L
 3.4%
H
124.0
128.7
|
L
 -1.3%
H
120.9
129.5
|
L
 9.4%
H
113.7
133
|
L
 28.9%
H
96.9
133
|
L
 55.1%
H
81.2
133
|
L
 37.8%
H
81.2
133
|
L
 -29.7%
H
81.2
201.1
|
L
 147.2%
H
45.4
201.1
|
| Qiagen NV |
|
8,648.0
|
41.9
|
L
 -1.5%
H
41.7
42.9
|
L
 -3.7%
H
41.7
42.9
|
L
 -3.1%
H
41.4
45.5
|
L
 13.0%
H
36.2
45.5
|
L
 -12.1%
H
32.5
57.8
|
L
 -10.3%
H
32.5
57.8
|
L
 -29.7%
H
32.5
64.7
|
L
 40.1%
H
27.8
65.9
|
| ResMed |
|
32,166.8
|
223.0
|
L
 2.2%
H
220.9
225.8
|
L
 -2.4%
H
215.8
226.7
|
L
 -1.7%
H
215.8
242.4
|
L
 14.5%
H
184.7
242.4
|
L
 -17.5%
H
180.3
284.9
|
L
 52.4%
H
132.2
293.8
|
L
 -22.8%
H
132.2
293.8
|
L
 244.5%
H
56.6
301.3
|
| Silvergate Cap Corp (Class A) |
|
382.0
|
18.4
|
L
 -1.0%
H
18.2
19.2
|
L
 -9.7%
H
18.2
20.5
|
L
 -4.6%
H
18.2
23.3
|
L
 -1.9%
H
17.6
24.6
|
L
 16.8%
H
10.9
24.6
|
L
 22.3%
H
10.9
24.6
|
L
 -83.2%
H
0.0
239.3
|
L
 -3.3%
H
0.0
239.3
|
| Steris PLC |
|
20,831.9
|
213.7
|
L
 1.4%
H
210.8
216.7
|
L
 -4.9%
H
209.6
223.0
|
L
 -9.5%
H
209.6
240.3
|
L
 2.9%
H
198.0
241.4
|
L
 -14.5%
H
195.1
269.4
|
L
 -7.3%
H
195.1
269.4
|
L
 1.6%
H
159.2
269.4
|
L
 205.1%
H
63.8
269.4
|
| Stevanato Grp Spa |
|
5,823.1
|
21.3
|
L
 2.0%
H
20.0
21.3
|
L
 4.0%
H
20
21.4
|
L
 -0.9%
H
19.7
23.2
|
L
 24.8%
H
16.3
23.2
|
L
 -19.3%
H
12.9
28
|
L
 -26.5%
H
12.9
35.6
|
L
 -18.8%
H
12.9
36.3
|
L
H
12.9
36.3
|
| Stryker |
|
108,117.7
|
281.9
|
L
 2.3%
H
280.7
287.2
|
L
 -7.0%
H
267
301.5
|
L
 -17.4%
H
267
343.9
|
L
 -9.7%
H
267
352.5
|
L
 -26.5%
H
267
392.6
|
L
 -5.2%
H
250.0
406.2
|
L
 4.1%
H
188.8
406.2
|
L
 155.0%
H
106.5
406.2
|
| Smith & Nephew PLC (ADR) |
|
11,885.8
|
28.4
|
L
 3.3%
H
28.2
28.5
|
L
 -1.6%
H
27.2
29.2
|
L
 -5.7%
H
27.2
30.4
|
L
 -7.1%
H
27.2
32.9
|
L
 -24.8%
H
27.2
37.8
|
L
 6.8%
H
21.5
38.8
|
L
 -23.5%
H
21.5
38.8
|
L
 -12.6%
H
21.5
52.3
|
| Teleflex Incorporated |
|
5,521.1
|
130.3
|
L
 -0.5%
H
129.5
134.3
|
L
 -5.8%
H
129.0
139.5
|
L
 -4.9%
H
129.0
144.2
|
L
 -0.1%
H
120.9
145
|
L
 0.0%
H
100.2
145
|
L
 -38.9%
H
100.2
257.9
|
L
 -65.5%
H
100.2
391.4
|
L
 -27.3%
H
100.2
449.4
|
| Thermo Fisher |
|
226,884.3
|
613.6
|
L
 0.6%
H
605.7
616
|
L
 0.0%
H
594.8
616
|
L
 3.0%
H
580
647
|
L
 30.9%
H
457.6
647
|
L
 28.1%
H
435.3
647
|
L
 20.1%
H
385.5
647
|
L
 9.7%
H
385.5
672.3
|
L
 322.7%
H
139.1
672.3
|
| Waters |
|
40,282.7
|
410.0
|
L
 0.4%
H
402.1
411.7
|
L
 0.2%
H
393.0
411.9
|
L
 -0.9%
H
393.0
426.2
|
L
 15.3%
H
345.2
426.2
|
L
 38.8%
H
282.8
426.2
|
L
 53.4%
H
231.9
426.2
|
L
 1.7%
H
231.9
426.2
|
L
 167.9%
H
133.4
428.2
|
| West Pharma Services |
|
24,997.5
|
355.2
|
L
 2.6%
H
345.2
356.6
|
L
 4.5%
H
332.0
356.6
|
L
 2.6%
H
332.0
360.3
|
L
 8.0%
H
321.9
386
|
L
 40.1%
H
223.8
386
|
L
 -10.1%
H
187.4
413.7
|
L
 -19.7%
H
187.4
475
|
L
 343.2%
H
70.2
475.4
|
| Zimmer Biomet Holdings |
|
18,413.8
|
96.5
|
L
 3.3%
H
94.7
97.0
|
L
 -1.6%
H
91.5
97.2
|
L
 -3.0%
H
91.5
102.9
|
L
 9%
H
83.7
102.9
|
L
 -6.3%
H
79.1
106.9
|
L
 -20.0%
H
79.1
133.9
|
L
 -27.2%
H
79.1
149.3
|
L
 -17.0%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
10,510.3
|
365.1
|
L
H
365.1
365.1
|
L
H
365.1
365.1
|
L
 8.3%
H
365.1
365.1
|
L
 20.0%
H
289.2
365.1
|
L
 47.8%
H
244.5
365.1
|
L
 9.9%
H
225.3
373.4
|
L
 9.9%
H
225.3
373.4
|
L
 9.9%
H
225.3
373.4
|
| Revvity |
|
14,337.7
|
128.5
|
L
 3.4%
H
124.0
128.7
|
L
 -1.3%
H
120.9
129.5
|
L
 9.4%
H
113.7
133
|
L
 28.9%
H
96.9
133
|
L
 55.1%
H
81.2
133
|
L
 14.8%
H
79.5
133
|
L
 -29.7%
H
79.5
203.2
|
L
 147.2%
H
45.4
203.2
|
| Aethlon Medical Inc |
|
1.1
|
1.5
|
L
 0.7%
H
1.5
1.6
|
L
 -15.4%
H
1.5
1.9
|
L
 -47.4%
H
1.5
3.3
|
L
 -23.8%
H
0.5
3.8
|
L
 -80.1%
H
0.5
8.3
|
L
 -99.2%
H
0.5
227.0
|
L
 -99.9%
H
0.5
4791.9
|
L
 -100.0%
H
0.5
64800
|
| Airsculpt Tech Inc |
|
171.6
|
2.4
|
L
 -1.7%
H
2.4
2.4
|
L
 -15%
H
2.4
3
|
L
 -29.6%
H
2.4
3.5
|
L
 -55.5%
H
2.4
5.5
|
L
 -61.6%
H
1.5
12
|
L
 -68.6%
H
1.5
12
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
| Align Tech |
|
10,869.1
|
153
|
L
 1.5%
H
150.7
153.9
|
L
 -3.6%
H
148.5
156.1
|
L
 -13.2%
H
148.5
182.2
|
L
 -12.5%
H
148.5
191.0
|
L
 16.3%
H
122
200.4
|
L
 -52.5%
H
122
335.7
|
L
 -78.5%
H
122
737.5
|
L
 66.3%
H
83.3
737.5
|
| Angiodynamic Inc |
|
641.1
|
15.5
|
L
 1.6%
H
15.1
15.6
|
L
 2.0%
H
14.9
15.6
|
L
 -1.0%
H
14.9
16.3
|
L
 28.2%
H
11.6
16.3
|
L
 45.6%
H
9.4
16.3
|
L
 108.5%
H
5.3
16.3
|
L
 -42.8%
H
5.3
32
|
L
 -4.3%
H
5.3
32
|
| Anika Therapeutics Inc |
|
283.6
|
21.2
|
L
 1.6%
H
20.8
21.4
|
L
 1.8%
H
20.2
21.4
|
L
 0.1%
H
20.1
22.5
|
L
 44.0%
H
13.8
22.9
|
L
 144.4%
H
8.6
22.9
|
L
 21.5%
H
7.9
29.1
|
L
 -46.6%
H
7.9
45.8
|
L
 -54.8%
H
7.9
75.7
|
| Anzu Special Acq Corp I (Class A) |
|
-
|
0.7
|
L
 -1.4%
H
0.7
0.8
|
L
 2.8%
H
0.7
0.8
|
L
 -2.7%
H
0.7
0.8
|
L
 15.9%
H
0.6
0.9
|
L
 -43.4%
H
0.4
1.9
|
L
 -93.0%
H
0.4
11.7
|
L
 -92.5%
H
0.4
11.7
|
L
H
0.4
11.7
|
| Apyx Medical Corp |
|
127.2
|
3.0
|
L
 4.1%
H
2.9
3.0
|
L
 -1.0%
H
2.8
3.1
|
L
 -0.7%
H
2.8
3.3
|
L
 -35.6%
H
2.8
4.9
|
L
 43.8%
H
1.7
5.1
|
L
 -28.3%
H
0.8
5.1
|
L
 -72.5%
H
0.8
17.5
|
L
 -28.1%
H
0.8
17.5
|
| Accuray Inc |
|
28.7
|
0.2
|
L
 -4%
H
0.2
0.3
|
L
 -11.1%
H
0.2
0.3
|
L
 -14.3%
H
0.2
0.3
|
L
 -29.4%
H
0.2
0.4
|
L
 -84.7%
H
0.2
2.1
|
L
 -91.1%
H
0.2
3.1
|
L
 -93.5%
H
0.2
5.9
|
L
 -95.6%
H
0.2
6.4
|
| Alphatec Holdings Inc |
|
1,677.3
|
10.9
|
L
 2.7%
H
10.4
11.0
|
L
 14.9%
H
8.6
11.0
|
L
 11.4%
H
8.6
11.0
|
L
 31.2%
H
8.0
11.0
|
L
 -28.8%
H
6.8
23.3
|
L
 -22.2%
H
4.9
23.3
|
L
 -22.6%
H
4.9
23.3
|
L
 127.7%
H
1.2
23.3
|
| Atricure Inc |
|
2,837.8
|
55.8
|
L
 2.3%
H
54.8
56.0
|
L
 8.3%
H
51.7
56.0
|
L
 28.3%
H
43.2
56.0
|
L
 93.8%
H
26.8
56.0
|
L
 59.1%
H
25.4
56.0
|
L
 26.2%
H
18.9
56.0
|
L
 -26.2%
H
18.9
89.2
|
L
 249.6%
H
14.8
89.2
|
| Axogen Inc |
|
2,353.7
|
43.8
|
L
 3.8%
H
41.6
44
|
L
 -9.3%
H
39.6
48.1
|
L
 -8.9%
H
39.6
52.9
|
L
 1.8%
H
38.2
52.9
|
L
 166.8%
H
15.3
52.9
|
L
 696%
H
3.5
52.9
|
L
 165.2%
H
3.5
52.9
|
L
 434.6%
H
3.5
56.9
|
| Bone Biologics Corp |
|
1.5
|
0.5
|
L
 -1.8%
H
0.5
0.6
|
L
 -5.3%
H
0.5
0.6
|
L
 -19.4%
H
0.5
0.7
|
L
 -56.8%
H
0.5
1.5
|
L
 -74.7%
H
0.5
2.9
|
L
 -98.3%
H
0.5
63.4
|
L
 -100.0%
H
0.5
10255.5
|
L
 -100.0%
H
0.5
169920
|
| BioAffinity Tech Inc |
|
4.8
|
7.9
|
L
 -0.3%
H
7.5
8.2
|
L
 -48.1%
H
7.5
12.3
|
L
 38.2%
H
4.6
20.4
|
L
 -64.3%
H
4.6
23.4
|
L
 -93.5%
H
4.6
202.5
|
L
 -98.9%
H
4.6
1629
|
L
H
4.6
6997.5
|
L
H
4.6
6997.5
|
| Bluejay Diagnostics Inc |
|
0.9
|
0.9
|
L
 -5.6%
H
0.9
0.9
|
L
 2.4%
H
0.9
1.1
|
L
 -19.8%
H
0.8
1.2
|
L
 -82.6%
H
0.8
4.9
|
L
 -86.5%
H
0.8
16.7
|
L
 -100.0%
H
0.8
9760
|
L
H
0.8
200000
|
L
H
0.8
200000
|
| Biolife Soln Inc |
|
1,733.4
|
35.4
|
L
 1.4%
H
34.6
35.5
|
L
 0.5%
H
34.4
36.1
|
L
 0.6%
H
34.4
38.1
|
L
 35.8%
H
24.8
38.1
|
L
 38.9%
H
17.9
38.1
|
L
 152.9%
H
8.9
38.1
|
L
 -31.6%
H
8.9
58.8
|
L
 1836.1%
H
1.4
60.7
|
| Biomerica Inc |
|
10.8
|
2.4
|
L
 5.4%
H
2.2
2.4
|
L
 2.2%
H
2.0
2.4
|
L
 45.7%
H
1.5
2.4
|
L
 15.1%
H
1.5
2.4
|
L
 -20.8%
H
1.5
3.2
|
L
 116.5%
H
0.2
4.9
|
L
 -48.5%
H
0.2
7.4
|
L
 -14.2%
H
0.2
23.4
|
| Bruker Corp |
|
8,023.2
|
52.7
|
L
 -1.4%
H
51.5
53.6
|
L
 -10.0%
H
51.5
58.6
|
L
 -9.1%
H
51.5
61.8
|
L
 -2.9%
H
48.6
65.3
|
L
 70.4%
H
30.1
65.3
|
L
 -18.3%
H
28.5
94.9
|
L
 -38.8%
H
28.5
94.9
|
L
 137.6%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
3.7
|
2.7
|
L
 1.1%
H
2.7
2.7
|
L
 -8.8%
H
2.6
3.2
|
L
 -38.6%
H
2.6
4.7
|
L
 -61.8%
H
2.6
8.6
|
L
 -91.2%
H
2.6
34.6
|
L
 -91%
H
2.6
73.4
|
L
 -99.2%
H
2.6
533.3
|
L
 -100.0%
H
2.6
400800
|
| Bioventus Inc (Class A) |
|
898.9
|
13.2
|
L
 1.4%
H
12.9
13.3
|
L
 -6.5%
H
12.9
14.1
|
L
 -5.3%
H
12.9
14.9
|
L
 54.6%
H
8.4
15.9
|
L
 82.0%
H
6.3
15.9
|
L
 324.5%
H
2.8
15.9
|
L
 -8.9%
H
0.8
17.5
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
548.0
|
13.6
|
L
 -2.2%
H
13.3
13.8
|
L
 -3.7%
H
13.3
14.5
|
L
 -17.2%
H
13.3
16.7
|
L
 -6.8%
H
13.3
17.4
|
L
 245.9%
H
3.6
17.4
|
L
 1334.7%
H
0.8
17.4
|
L
 574.8%
H
0.3
17.4
|
L
H
0.3
17.4
|
| Cardio Diagnostics Holdings Inc |
|
6.1
|
2.1
|
L
 2.0%
H
2.0
2.1
|
L
 11.3%
H
1.9
2.1
|
L
 3.0%
H
1.8
2.3
|
L
 5.6%
H
1.4
2.3
|
L
 -45.4%
H
1.0
7.9
|
L
 -85%
H
1.0
106.8
|
L
H
1.0
307.5
|
L
H
1.0
307.5
|
| Caredx Inc |
|
2,709.3
|
52.4
|
L
 4.2%
H
50.2
52.7
|
L
 2.9%
H
48.6
52.7
|
L
 10.5%
H
44.8
53.7
|
L
 128.0%
H
22.7
53.7
|
L
 287.1%
H
13.4
53.7
|
L
 523.5%
H
4.8
53.7
|
L
 -18.2%
H
4.8
75.9
|
L
 1106.7%
H
0.8
99.8
|
| Celcuity Inc |
|
4,087.3
|
83.5
|
L
 0.1%
H
82.5
84.9
|
L
 -12.7%
H
82.5
97.4
|
L
 -3.6%
H
82.5
98
|
L
 -5.7%
H
78.6
117.2
|
L
 52.1%
H
44.4
151.0
|
L
 781.1%
H
7.6
151.0
|
L
 289.4%
H
4.8
151.0
|
L
H
4.0
151.0
|
| Creative Medical Tech Holdings Inc |
|
5.8
|
0.9
|
L
 -8.3%
H
0.9
1.0
|
L
 -20.7%
H
0.9
1.1
|
L
 -29.0%
H
0.9
1.4
|
L
 -59.5%
H
0.6
4.7
|
L
 -74.9%
H
0.6
6.3
|
L
 -84.4%
H
0.6
10.3
|
L
 -99.0%
H
0.6
100
|
L
 -100.0%
H
0.6
525000
|
| Cerus Corp |
|
513.9
|
2.6
|
L
 2.4%
H
2.5
2.6
|
L
 -1.5%
H
2.5
2.6
|
L
 -10.2%
H
2.5
3.1
|
L
 -0.4%
H
2.1
3.5
|
L
 107.3%
H
1.2
3.5
|
L
 52.7%
H
1.1
3.5
|
L
 -58.3%
H
1.1
8.1
|
L
 -57.9%
H
1.1
8.9
|
| Check-Cap Ltd |
|
8.7
|
6.3
|
L
 -1.6%
H
6.3
6.4
|
L
 -3.1%
H
6.1
6.8
|
L
 -28.7%
H
6.0
9.2
|
L
 -35.3%
H
1.2
10.5
|
L
 20.7%
H
1.2
27.4
|
L
 -74.5%
H
1.2
32.4
|
L
 -95.5%
H
1.2
183.4
|
L
 -99.8%
H
1.2
4956
|
| Ridgetech Inc |
|
3.0
|
0.8
|
L
 1.2%
H
0.8
0.9
|
L
 -7.7%
H
0.8
0.9
|
L
 -4.6%
H
0.8
1.2
|
L
 -41.3%
H
0.7
3.1
|
L
 -99.6%
H
0.7
760.5
|
L
 -99.9%
H
0.7
810
|
L
 -100.0%
H
0.7
35370
|
L
 -100.0%
H
0.7
124560
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
6.6
|
3.5
|
L
 -0.3%
H
3.4
3.6
|
L
 -1.7%
H
3.3
3.7
|
L
 9.4%
H
2.6
9.6
|
L
 3.0%
H
2.6
9.6
|
L
 -86.7%
H
2.6
31.8
|
L
 -94.9%
H
2.6
74.9
|
L
 -98.1%
H
2.6
230
|
L
 -98.0%
H
2.6
242.6
|
| ClearPoint Neuro Inc |
|
410.6
|
13.5
|
L
 -1.9%
H
13.5
13.9
|
L
 -3.6%
H
13.3
14.2
|
L
 -12.7%
H
13.3
17.2
|
L
 0.2%
H
12.3
19.6
|
L
 28.3%
H
8.3
30.1
|
L
 158.3%
H
4.1
30.1
|
L
 -26.6%
H
4.1
30.1
|
L
 100%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
101.9
|
1.3
|
L
 8.3%
H
1.2
1.3
|
L
 20.2%
H
1.0
1.3
|
L
 33.7%
H
0.9
1.3
|
L
 -14.9%
H
0.8
1.6
|
L
 -36.1%
H
0.8
3.3
|
L
 -24.7%
H
0.8
6.4
|
L
 -80.6%
H
0.8
7.6
|
L
 -99.6%
H
0.7
360
|
| Castle Biosciences Inc |
|
1,021.6
|
33.4
|
L
 3.4%
H
32.2
33.5
|
L
 1.6%
H
31.4
33.6
|
L
 9.5%
H
28.7
35.2
|
L
 61.6%
H
19.9
35.2
|
L
 56.1%
H
17.7
44.3
|
L
 80.7%
H
12.1
44.3
|
L
 -54.3%
H
9.3
78.5
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
627.8
|
4.8
|
L
 4.8%
H
4.6
4.9
|
L
 2.8%
H
4.5
4.9
|
L
 -1.2%
H
4.3
4.9
|
L
 22.0%
H
3.7
4.9
|
L
 22.6%
H
3.3
6.2
|
L
 -33.5%
H
2.4
9.9
|
L
 -81.5%
H
2.4
28.7
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
19.1
|
6.1
|
L
 -5.3%
H
5.1
6.3
|
L
 -13.3%
H
5.1
7.4
|
L
 -16.2%
H
5.1
9.4
|
L
 -24.1%
H
5.1
12.1
|
L
 -67.7%
H
5.1
20.4
|
L
 -85.1%
H
5.1
42.8
|
L
 -96.5%
H
5.1
177.2
|
L
 -94.7%
H
5.1
299
|
| Citius Pharma Inc |
|
15.6
|
0.6
|
L
 -1.7%
H
0.6
0.6
|
L
 -3.4%
H
0.6
0.6
|
L
 -21.9%
H
0.6
0.8
|
L
 5.6%
H
0.5
0.8
|
L
 -52.9%
H
0.5
2.2
|
L
 -96.9%
H
0.1
26.8
|
L
 -98.9%
H
0.1
56.3
|
L
 -99.8%
H
0.1
371.3
|
| CVRx Inc |
|
79.9
|
3
|
L
 4.2%
H
2.8
3
|
L
 -1.6%
H
2.7
3.1
|
L
 2.0%
H
2.7
3.4
|
L
 -40.4%
H
2.2
6.0
|
L
 -61.9%
H
2.2
11.3
|
L
 -80.7%
H
2.2
33.1
|
L
 -83.6%
H
2.2
33.1
|
L
H
2.2
33.1
|
| Delcath Systems Inc |
|
570.4
|
16.4
|
L
 3.3%
H
16.0
16.5
|
L
 -0.2%
H
15.7
16.5
|
L
 -5.3%
H
15.7
17.4
|
L
 40.3%
H
11.4
17.4
|
L
 51.7%
H
8.1
17.4
|
L
 262.9%
H
2.3
18.2
|
L
 63.3%
H
2.3
18.2
|
L
 -100.0%
H
2.3
527975000
|
| DarioHealth Corp |
|
69.5
|
7.1
|
L
 2.3%
H
6.8
7.1
|
L
 -2.1%
H
6.5
7.3
|
L
 -3.3%
H
6.5
8.1
|
L
 0.4%
H
5.8
8.2
|
L
 -0.3%
H
5.8
17.7
|
L
 -87.8%
H
5.8
69.8
|
L
 -97.2%
H
5.8
387.8
|
L
 -99.5%
H
5.8
1880
|
| Alpha Tau Medical Ltd |
|
1,331.7
|
14.4
|
L
 -0.2%
H
14.1
14.8
|
L
 -4.2%
H
13.8
15.1
|
L
 -0.7%
H
13.7
15.2
|
L
 46.2%
H
9.2
15.2
|
L
 278.0%
H
3.4
15.2
|
L
 336.4%
H
1.8
15.2
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
31,954.9
|
84.7
|
L
 2.0%
H
83.8
85.0
|
L
 -3.7%
H
82.3
86.8
|
L
 -7.4%
H
82.3
92.6
|
L
 12.4%
H
67.3
92.6
|
L
 11.1%
H
54.1
92.6
|
L
 -19.5%
H
54.1
142
|
L
 -37.3%
H
54.1
164.9
|
L
 268.7%
H
10.7
164.9
|
| ElectroCore Inc |
|
88.0
|
9.8
|
L
 1.5%
H
9.5
9.9
|
L
 6.0%
H
8.7
10.0
|
L
 -1.8%
H
8.7
11.0
|
L
 -4.8%
H
5.6
11.0
|
L
 105.9%
H
4.4
11.0
|
L
 74.3%
H
4.2
19.5
|
L
 -37.4%
H
2.9
19.5
|
L
H
2.9
303.8
|
| ChronoScale Corp |
|
2,739.4
|
18.8
|
L
 -1%
H
18
19.5
|
L
 -7.2%
H
17.8
22
|
L
 -8.8%
H
17.3
25
|
L
 2.5%
H
15.7
30
|
L
 391.1%
H
3.5
30
|
L
 -89%
H
2.7
704.0
|
L
 -98.1%
H
2.7
1164.2
|
L
 -99.9%
H
2.7
21532.5
|
| Embecta Corp |
|
296.9
|
5.2
|
L
 6.1%
H
5.0
5.3
|
L
 -9.7%
H
4.9
5.8
|
L
 2.5%
H
4.8
5.9
|
L
 69.0%
H
3.0
5.9
|
L
 -65.1%
H
2.8
15.6
|
L
 -68.4%
H
2.8
21.5
|
L
H
2.8
63
|
L
H
2.8
63
|
| Establishment Labs Holdings Inc |
|
2,143.4
|
71.9
|
L
 1.4%
H
70.3
72.0
|
L
 -3.2%
H
70.2
75.8
|
L
 -4.9%
H
67.1
81.3
|
L
 -12.4%
H
67.1
97.6
|
L
 92.0%
H
36.6
97.6
|
L
 36.5%
H
17
97.6
|
L
 1.1%
H
17
97.6
|
L
H
7.6
97.6
|
| EDAP TMS S.A. (ADR) |
|
154.1
|
4.1
|
L
 0.2%
H
4.0
4.1
|
L
 -1.0%
H
4.0
4.3
|
L
 -11.2%
H
4.0
4.8
|
L
 -12.9%
H
4.0
6.4
|
L
 67.8%
H
1.8
6.4
|
L
 -36.6%
H
1.2
8.5
|
L
 -31.5%
H
1.2
12.7
|
L
 42.2%
H
1.2
12.7
|
| GlucoTrack Inc |
|
2.0
|
2.5
|
L
 -3.9%
H
2.3
2.7
|
L
 -17.8%
H
2.3
3.3
|
L
 -55.4%
H
2.3
6.1
|
L
 -57.7%
H
2.3
13.5
|
L
 -98.5%
H
2.3
136.3
|
L
 -100.0%
H
2.3
89100
|
L
 -100.0%
H
2.3
576000
|
L
 -100.0%
H
2.3
7020000
|
| GE HealthCare Tech |
|
29,020.8
|
64.3
|
L
 0.5%
H
63.9
65.3
|
L
 -6.7%
H
63.2
68.1
|
L
 -12.9%
H
63.2
75.7
|
L
 -1.4%
H
60.0
75.7
|
L
 -16.0%
H
58.8
89.8
|
L
 -0.4%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Guardant Health Inc |
|
22,523.5
|
167.8
|
L
 6.7%
H
155.8
168.2
|
L
 4.0%
H
155.8
168.2
|
L
 5.2%
H
154
173.2
|
L
 27.5%
H
125
176.6
|
L
 205.7%
H
53.4
176.6
|
L
 420.4%
H
15.8
176.6
|
L
 32.7%
H
15.8
176.6
|
L
H
15.8
181.1
|
| Harvard Bioscience Inc |
|
36.8
|
8.1
|
L
 0.8%
H
8.0
8.1
|
L
 0.9%
H
7.9
8.2
|
L
 21.3%
H
6.5
8.4
|
L
 33.1%
H
5.8
8.4
|
L
 83.0%
H
3.8
9.4
|
L
 -80.6%
H
2.8
55.6
|
L
 -89.5%
H
2.8
82.3
|
L
 -69.0%
H
2.8
87.5
|
| Cue Health Inc |
|
4,460.9
|
28.0
|
L
 1.5%
H
27.5
28.0
|
L
 -1.7%
H
27.3
29.1
|
L
 1.9%
H
26.5
31.2
|
L
H
24.9
31.2
|
L
H
24.9
31.2
|
L
 4496.7%
H
0
31.2
|
L
H
0
31.2
|
L
H
0
31.2
|
| Heart Test Laboratories Inc |
|
16.0
|
3.5
|
L
 4.4%
H
3.3
3.6
|
L
 -5.1%
H
3.3
4.4
|
L
 71.8%
H
2
4.4
|
L
 96.7%
H
1.7
4.4
|
L
 18%
H
1.6
4.4
|
L
 -95.7%
H
1.6
85.2
|
L
H
1.6
600
|
L
H
1.6
600
|
| Helius Medical Tech Inc (Class A) |
|
139.7
|
2.3
|
L
 4.1%
H
2.2
2.3
|
L
 3.1%
H
2.1
2.3
|
L
 28.3%
H
1.6
2.5
|
L
 50%
H
1.4
2.5
|
L
 -69.4%
H
1.2
25.5
|
L
 -100.0%
H
1.2
8242.5
|
L
 -100.0%
H
1.2
579375
|
L
 -100.0%
H
1.2
27168750
|
| Henry Schein |
|
9,910.9
|
88.9
|
L
 0.7%
H
87.6
89.1
|
L
 -1.0%
H
87.1
90.0
|
L
 -1.3%
H
87.1
91.7
|
L
 9.5%
H
78.6
92.2
|
L
 28.9%
H
61.9
92.2
|
L
 21.5%
H
60.0
92.2
|
L
 14.4%
H
60.0
92.7
|
L
 41.7%
H
41.9
92.7
|
| Hyperfine Inc (Class A) |
|
84.8
|
0.8
|
L
 1.3%
H
0.8
0.8
|
L
 -1.2%
H
0.8
0.8
|
L
 -10.1%
H
0.8
0.9
|
L
 -41.2%
H
0.8
1.7
|
L
 -43.7%
H
0.8
2.2
|
L
 -61.0%
H
0.5
2.2
|
L
 -91.9%
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
1,221.8
|
15.7
|
L
 1.4%
H
15.4
15.8
|
L
 -6.0%
H
15.3
16.6
|
L
 -13.9%
H
15.3
18.5
|
L
 -11.6%
H
15.3
20.5
|
L
 4.3%
H
8.7
20.5
|
L
 -59.8%
H
8.7
45.4
|
L
 -77.3%
H
8.7
75.0
|
L
 -62.9%
H
8.7
77.4
|
| Icecure Medical Ltd |
|
7.2
|
2.1
|
L
 -5.4%
H
2.1
2.2
|
L
 -6.3%
H
2.1
2.5
|
L
 -30.3%
H
2.1
3.2
|
L
 -12.6%
H
2.1
9.5
|
L
 -92.9%
H
2.1
42
|
L
 -93.5%
H
2.1
49.8
|
L
 -99.3%
H
2.1
309
|
L
 -94.0%
H
2.1
480
|
| SeaStar Medical Holding Corp |
|
13.5
|
3.1
|
L
 1.3%
H
3.0
3.1
|
L
 3.0%
H
2.9
3.3
|
L
 -3.2%
H
2.8
3.5
|
L
 3.0%
H
2.8
5.4
|
L
 -96.5%
H
2.1
125
|
L
 -99.4%
H
2.1
4292.3
|
L
 -100.0%
H
2.1
55000
|
L
H
2.1
55000
|
| ICU Medical Inc |
|
3,941.1
|
157.6
|
L
 0.7%
H
155.7
158.7
|
L
 -6.0%
H
155.5
166.6
|
L
 -13.9%
H
155.5
189.3
|
L
 10.8%
H
135.1
192.9
|
L
 20.9%
H
112.5
192.9
|
L
 25.5%
H
78.4
196.3
|
L
 -34.4%
H
78.4
251.8
|
L
 29.7%
H
78.4
321.7
|
| Idexx Laboratories |
|
40,143.7
|
509.6
|
L
 1.0%
H
505.0
515.5
|
L
 -4.8%
H
500.6
529.0
|
L
 -10.1%
H
500.6
575.6
|
L
 -9.2%
H
500.6
624.2
|
L
 -20.5%
H
500.6
770.0
|
L
 11.2%
H
356.3
770.0
|
L
 -22.2%
H
317.1
770.0
|
L
 371.1%
H
102.5
770.0
|
| QTREX Quantum |
|
57.7
|
0.9
|
L
 -3.4%
H
0.9
0.9
|
L
 3.6%
H
0.8
0.9
|
L
 -14%
H
0.8
1.4
|
L
 -33.3%
H
0.8
2.6
|
L
 -28.9%
H
0.3
3.9
|
L
 -41.9%
H
0.3
3.9
|
L
 -73.1%
H
0.3
9.6
|
L
H
0.3
9.6
|
| Illumina Inc |
|
31,439.7
|
208.2
|
L
 0.9%
H
202.8
208.9
|
L
 -4.6%
H
200.0
219.5
|
L
 8.1%
H
187.5
231.8
|
L
 29.4%
H
157.6
231.8
|
L
 118.9%
H
88
231.8
|
L
 38.1%
H
68.7
231.8
|
L
 -54.0%
H
68.7
455.9
|
L
 22.4%
H
68.7
555.8
|
| Intercure Ltd |
|
79.4
|
5.3
|
L
 2.5%
H
5.1
5.3
|
L
 -2.4%
H
5.1
5.6
|
L
 14.3%
H
4.2
6.1
|
L
 21.1%
H
4.2
6.1
|
L
 -32.6%
H
3.4
8.5
|
L
 -35.5%
H
3.4
18.6
|
L
 -85.8%
H
3.4
43.9
|
L
H
3.4
96.8
|
| Inogen Inc |
|
138.8
|
5.2
|
L
 -1.5%
H
5.2
5.4
|
L
 -3.5%
H
5.2
5.5
|
L
 -10.0%
H
5.2
5.8
|
L
 -18.3%
H
5.2
7.1
|
L
 -38.8%
H
5.2
9.1
|
L
 -9.7%
H
4.1
13.3
|
L
 -89.2%
H
4.1
50.2
|
L
 -90.8%
H
4.1
287.8
|
| Inmode Ltd |
|
856.8
|
14.9
|
L
 -0.1%
H
14.8
15.0
|
L
 -0.1%
H
14.6
15.0
|
L
 -2.0%
H
14.6
15.3
|
L
 10.7%
H
13.2
15.7
|
L
 0.4%
H
12.7
16.7
|
L
 -56.8%
H
12.7
35.6
|
L
 -75.8%
H
12.7
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
2.4
|
1.0
|
L
 -2.1%
H
1.0
1
|
L
 -3.1%
H
1.0
1
|
L
 -2.1%
H
1.0
2.8
|
L
 -35.8%
H
0.9
3.1
|
L
 -97.7%
H
0.9
84.4
|
L
 -99.9%
H
0.9
5040
|
L
 -100.0%
H
0.9
123264
|
L
 -100.0%
H
0.9
709632
|
| IRIDEX Corp |
|
11.2
|
0.6
|
L
 -3.0%
H
0.6
0.7
|
L
 -8.6%
H
0.6
0.7
|
L
 -22.0%
H
0.6
1.0
|
L
 -42.9%
H
0.6
1.2
|
L
 -51.5%
H
0.6
1.7
|
L
 -64.6%
H
0.6
3.7
|
L
 -91.3%
H
0.6
9.5
|
L
 -95.8%
H
0.6
16.4
|
| Iradimed Corp |
|
1,055.3
|
82.5
|
L
 0.4%
H
82.2
84.1
|
L
 -1.1%
H
81.4
86.8
|
L
 -5.1%
H
81.4
89.1
|
L
 -11.8%
H
81.4
103.0
|
L
 15.8%
H
67.8
107.9
|
L
 86.7%
H
36.1
107.9
|
L
 137.8%
H
26
107.9
|
L
 374.6%
H
7.9
107.9
|
| iRhythm Tech Inc |
|
3,781.5
|
114.7
|
L
 3.0%
H
112.5
115.5
|
L
 -6.8%
H
110.2
124.9
|
L
 -6.9%
H
110.2
130.0
|
L
 0.9%
H
100.9
136.7
|
L
 -36.2%
H
100.9
212
|
L
 18.9%
H
55.9
212
|
L
 76.6%
H
55.9
212
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
135,407.6
|
377.9
|
L
 2.4%
H
372.2
378.6
|
L
 3.1%
H
345.3
378.6
|
L
 -5.8%
H
345.3
405.3
|
L
 -8.1%
H
328.6
443.8
|
L
 -16.0%
H
328.6
603.9
|
L
 24.9%
H
254.9
616
|
L
 10.3%
H
180.1
616
|
L
 406.0%
H
67.9
616
|
| Jowell Global Ltd |
|
5.1
|
2.2
|
L
 -4.0%
H
2.1
2.2
|
L
 -5.7%
H
2.0
2.4
|
L
 -32.0%
H
2.0
3.1
|
L
 -17.3%
H
1.5
5.2
|
L
 16.2%
H
1.5
5.2
|
L
 -38.4%
H
1
5.6
|
L
 -97.7%
H
1
412.5
|
L
H
1
412.5
|
| Kewaunee Scientific Corp |
|
101.5
|
35.1
|
L
 1.7%
H
34.0
35.9
|
L
 -5.2%
H
32
37.7
|
L
 -4.1%
H
32
39
|
L
 -4.6%
H
32
39
|
L
 -17.3%
H
32
46.7
|
L
 89.6%
H
16.5
71.3
|
L
 169.4%
H
12.1
71.3
|
L
 37.7%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
583.3
|
22.3
|
L
 1.3%
H
22.0
22.6
|
L
 -0.3%
H
21
22.6
|
L
 -10.7%
H
21
26.7
|
L
 25.4%
H
17.6
26.7
|
L
 13.7%
H
14.4
26.7
|
L
 -33.2%
H
14.4
36.1
|
L
 -67.4%
H
14.4
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
145.0
|
3.1
|
L
 -0.6%
H
3.1
3.2
|
L
 -3.4%
H
3.1
3.3
|
L
 -5.4%
H
3.1
3.5
|
L
 -21.5%
H
3.1
4.7
|
L
 -19.9%
H
3.1
6.6
|
L
 23.6%
H
1.9
6.6
|
L
 5.7%
H
1.8
6.6
|
L
 685%
H
0.3
12.8
|
| Standard BioTools Inc |
|
274.8
|
0.7
|
L
 1.5%
H
0.7
0.7
|
L
 1.5%
H
0.7
0.7
|
L
 -6.7%
H
0.6
0.8
|
L
 -21.4%
H
0.6
1.0
|
L
 -45.7%
H
0.6
1.7
|
L
 -75.8%
H
0.6
3.1
|
L
 -89.8%
H
0.6
7.1
|
L
 -91.1%
H
0.6
14.9
|
| LivaNova PLC |
|
4,442.2
|
80.6
|
L
 3.1%
H
78.3
80.8
|
L
 -1.6%
H
77.2
81.8
|
L
 -1.9%
H
77.2
83.5
|
L
 1.6%
H
74.7
85.8
|
L
 43.4%
H
48.8
85.8
|
L
 41.5%
H
32.5
85.8
|
L
 -3.4%
H
32.5
93.9
|
L
 34.7%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
1,847.2
|
80.8
|
L
 0.2%
H
80
81.8
|
L
 0.1%
H
78.3
81.8
|
L
 -1.4%
H
78.3
84.4
|
L
 -12.2%
H
78.3
106.3
|
L
 -12.5%
H
78.3
118.0
|
L
 44.3%
H
44.3
118.0
|
L
 41.8%
H
38.3
118.0
|
L
 296.1%
H
18.6
118.0
|
| LENSAR Inc |
|
96.0
|
7.8
|
L
 2.8%
H
7.7
8.0
|
L
 -9.0%
H
7.6
8.7
|
L
 -5.6%
H
7.6
9.3
|
L
 34.2%
H
5.0
9.3
|
L
 -37.4%
H
5.0
12.9
|
L
 156.9%
H
1.8
17.3
|
L
 -4.2%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
6,550.9
|
100.3
|
L
 0.1%
H
100.2
100.5
|
L
 -0.6%
H
100.2
101.0
|
L
 -0.6%
H
100.0
101.4
|
L
 -4.0%
H
98.8
111.9
|
L
 89.5%
H
49.7
111.9
|
L
 60.8%
H
47.3
126.9
|
L
 300.2%
H
22.2
126.9
|
L
 1174.7%
H
7.6
126.9
|
| Lucid Diagnostics Inc |
|
148.9
|
0.8
|
L
H
0.8
0.8
|
L
 -17.0%
H
0.8
0.9
|
L
 -18.8%
H
0.8
1.0
|
L
 -18.8%
H
0.8
1.2
|
L
 -24.3%
H
0.8
1.6
|
L
 -49.7%
H
0.6
1.8
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
| Pulmonx Corp |
|
84.6
|
2.0
|
L
 6.5%
H
1.8
2
|
L
 -10.9%
H
1.8
2.2
|
L
 -8.8%
H
1.8
2.6
|
L
 43.8%
H
1.2
2.6
|
L
 15.9%
H
1.1
2.9
|
L
 -80.7%
H
1.1
14.8
|
L
 -94.8%
H
1.1
45.5
|
L
H
1.1
69.5
|
| 908 Devices Inc |
|
402.2
|
9.7
|
L
 2.2%
H
9.3
9.9
|
L
 -3.2%
H
9.3
10
|
L
 -3.8%
H
9.3
11.3
|
L
 17.7%
H
6.9
11.3
|
L
 73.8%
H
5.0
11.3
|
L
 51.8%
H
1.8
12.5
|
L
 -73.3%
H
1.8
39.3
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
677.1
|
4.6
|
L
 1.5%
H
4.5
4.7
|
L
 1.5%
H
4.4
4.7
|
L
 10.5%
H
4.1
4.8
|
L
 28.9%
H
3.6
4.8
|
L
 -33.1%
H
3.0
8.0
|
L
 -39.0%
H
3.0
10.1
|
L
 -26.1%
H
2.4
10.1
|
L
 -45.3%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
679.8
|
121.5
|
L
 0.5%
H
119.1
122.7
|
L
 -4.9%
H
119.1
127.2
|
L
 7.3%
H
103.9
132.7
|
L
 15.2%
H
87.2
132.7
|
L
 97.0%
H
61.4
132.7
|
L
 -1.1%
H
55.5
155.1
|
L
 -56.6%
H
55.5
333.4
|
L
 5.5%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
5,196.0
|
87.0
|
L
 0.8%
H
86.0
87.8
|
L
 -2.9%
H
85.2
88.9
|
L
 -3.9%
H
85.2
92.2
|
L
 30.8%
H
64.5
92.3
|
L
 1.7%
H
59.7
94.8
|
L
 28.4%
H
59.7
111.5
|
L
 21.5%
H
50.5
111.5
|
L
 261.2%
H
19.5
111.5
|
| Modular Medical Inc |
|
21.0
|
2.6
|
L
 1.6%
H
2.3
2.7
|
L
 -29.9%
H
2.3
3.6
|
L
 38.0%
H
1.7
4.0
|
L
 -45.9%
H
1.7
6
|
L
 -88.5%
H
1.7
24.9
|
L
 -92.3%
H
1.7
79.5
|
L
 -99.2%
H
1.7
450
|
L
 -89.4%
H
1.7
585.0
|
| MedTech Acq Corp (Class A) |
|
-
|
4.8
|
L
 2.4%
H
4.6
4.8
|
L
 -4.6%
H
4.5
5.0
|
L
 -15.3%
H
4.5
5.6
|
L
 26.5%
H
3.7
5.9
|
L
 7.7%
H
2.2
8.0
|
L
 -7.2%
H
2.2
8.0
|
L
 -51.6%
H
2.2
12.8
|
L
H
2.2
12.8
|
| Myriad Genetics Inc |
|
362.5
|
3.8
|
L
 10.8%
H
3.4
3.8
|
L
 18.8%
H
3.1
3.8
|
L
 19.6%
H
2.8
3.8
|
L
 -12.5%
H
2.7
6.4
|
L
 -47.7%
H
2.7
8.6
|
L
 -76.3%
H
2.7
29.3
|
L
 -88.4%
H
2.7
35.3
|
L
 -81.9%
H
2.7
50.4
|
| MDxHealth SA (ADR) |
|
-
|
0.7
|
L
 1.4%
H
0.7
0.7
|
L
 -5.3%
H
0.7
0.8
|
L
 54.4%
H
0.6
1.1
|
L
 31.5%
H
0.4
1.1
|
L
 -80.8%
H
0.4
5.3
|
L
 -76.2%
H
0.4
5.3
|
L
H
0.4
13.2
|
L
H
0.4
13.2
|
| ENvue Medical Inc |
|
3.1
|
3.4
|
L
 -6.4%
H
3.3
3.6
|
L
 -16.9%
H
3.3
4.6
|
L
 781.6%
H
0.3
4.6
|
L
 303.6%
H
0.3
4.6
|
L
 -48.4%
H
0.3
17.4
|
L
 -98.9%
H
0.3
319
|
L
 -99.9%
H
0.3
5038
|
L
 -100.0%
H
0.3
16104
|
| ENDRA Life Sciences Inc |
|
8.8
|
5.9
|
L
 4.5%
H
5.5
5.9
|
L
 -3.0%
H
5.5
6.6
|
L
 31.3%
H
4.2
6.8
|
L
 28.7%
H
3.6
6.8
|
L
 23.8%
H
3.0
9.9
|
L
 -88.5%
H
0.0
139.5
|
L
 -99.7%
H
0.0
1846.9
|
L
H
0.0
5880
|
| Neogen Corp |
|
2,606.4
|
12.0
|
L
 1.4%
H
11.7
12.0
|
L
 1.0%
H
11.6
12.4
|
L
 0.5%
H
11.4
12.4
|
L
 31.3%
H
8.7
12.9
|
L
 117.3%
H
4.9
12.9
|
L
 -44.2%
H
3.9
21.9
|
L
 -71.7%
H
3.9
47.8
|
L
 -43.8%
H
3.9
48.9
|
| Nephros Inc |
|
48.1
|
4.4
|
L
 -0.9%
H
4.4
4.6
|
L
 9.1%
H
4.1
4.8
|
L
 -5.5%
H
3.8
4.9
|
L
 32.6%
H
3.1
4.9
|
L
 4.0%
H
2.7
6.4
|
L
 209.8%
H
1.4
6.4
|
L
 -48.6%
H
0.9
9.1
|
L
 4.7%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
13.7
|
1.5
|
L
 -3.9%
H
1.5
1.6
|
L
 -7.4%
H
1.5
1.7
|
L
 -18.0%
H
1.5
3.5
|
L
 -53.7%
H
1.4
3.5
|
L
 -71.9%
H
1.4
7.0
|
L
 -75%
H
1.4
12
|
L
 -94.7%
H
1.4
29.9
|
L
H
1.4
180
|
| Nano X Imaging Ltd |
|
55.0
|
0.7
|
L
 -2.8%
H
0.7
0.8
|
L
 -15.7%
H
0.7
1.0
|
L
 -28.6%
H
0.7
1.0
|
L
 -60.2%
H
0.7
1.9
|
L
 -82.1%
H
0.7
4.7
|
L
 -90.6%
H
0.7
14.3
|
L
 -96.9%
H
0.7
28.6
|
L
H
0.7
94.8
|
| NeuroPace Inc |
|
500.8
|
14.6
|
L
 3.9%
H
14.0
14.7
|
L
 -2.1%
H
13.8
15.1
|
L
 0.6%
H
13.6
15.6
|
L
 -6.7%
H
12.7
18.2
|
L
 48.0%
H
9.2
19.6
|
L
 75.6%
H
5.5
19.6
|
L
 -23.8%
H
1.2
20.2
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
37.9
|
0.8
|
L
 2.5%
H
0.8
0.8
|
L
 -4.7%
H
0.8
0.9
|
L
 -3.6%
H
0.8
1.0
|
L
 11.0%
H
0.6
1.0
|
L
 -66.0%
H
0.6
2.6
|
L
 -77.2%
H
0.6
3.9
|
L
 -80.2%
H
0.6
5.1
|
L
 -100.0%
H
0.6
115237.5
|
| Nortech Systems Inc |
|
31.9
|
11.2
|
L
 -0.1%
H
11.1
11.5
|
L
 -4.5%
H
11.1
12.1
|
L
 -12.3%
H
11.1
12.8
|
L
 -32.1%
H
11.1
17.6
|
L
 16.5%
H
6.5
18.0
|
L
 12.1%
H
6.5
19.2
|
L
 -5.1%
H
6.5
19.6
|
L
 202.2%
H
2.5
19.6
|
| Nutriband Inc |
|
84.1
|
6.9
|
L
 -0.6%
H
6.5
7.0
|
L
 15.9%
H
5.5
7.0
|
L
 116.9%
H
3.2
7.0
|
L
 104.1%
H
2.8
7.0
|
L
 -3.2%
H
2.8
8.6
|
L
 168.2%
H
1.5
11.8
|
L
 -19.3%
H
1.5
11.8
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
2.5
|
0.8
|
L
 3.9%
H
0.8
0.8
|
L
 2.6%
H
0.8
0.8
|
L
 -38.5%
H
0.7
1.4
|
L
 471.4%
H
0.1
6.4
|
L
 -80.9%
H
0.1
6.4
|
L
 -100.0%
H
0.1
2646
|
L
 -100.0%
H
0.1
593880
|
L
 -100.0%
H
0.1
10000000000
|
| NovoCure Ltd |
|
1,888.8
|
16.2
|
L
 4.6%
H
15.3
16.3
|
L
 -9.6%
H
15.1
17.8
|
L
 -6.7%
H
15.1
18.6
|
L
 -8.8%
H
13.4
21.5
|
L
 33.5%
H
9.8
21.5
|
L
 -18.7%
H
9.8
34.1
|
L
 -87.5%
H
9.8
132.4
|
L
 97.8%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
6.5
|
9.4
|
L
 -10.6%
H
9.3
10.3
|
L
 -18.0%
H
9.3
11.8
|
L
 -13.6%
H
9.3
12.5
|
L
 -6.2%
H
9.3
12.5
|
L
 -65.7%
H
8.7
35.7
|
L
 -95.0%
H
8.7
244.0
|
L
 -96.9%
H
8.7
398.3
|
L
H
8.7
4935
|
| Nexalin Tech Inc |
|
4.1
|
5.0
|
L
 3.5%
H
4.9
5.0
|
L
 -1.4%
H
4.5
5.5
|
L
 -52.5%
H
4.5
10.8
|
L
 -61.4%
H
4.5
15.5
|
L
 -81.0%
H
4.5
60
|
L
 -60.4%
H
4.5
134.7
|
L
H
4.5
134.7
|
L
H
4.5
134.7
|
| Nyxoah SA |
|
162.9
|
1.6
|
L
 3.9%
H
1.5
1.6
|
L
 -1.2%
H
1.5
1.6
|
L
 1.3%
H
1.5
1.8
|
L
 15.1%
H
1.3
1.9
|
L
 -69.5%
H
1.3
6.9
|
L
 -79.4%
H
1.3
20
|
L
 -94.5%
H
1.3
31.6
|
L
H
1.3
37
|
| Orchestra BioMed Holdings Inc |
|
354.6
|
5.9
|
L
 -3.6%
H
5.7
6.2
|
L
 16.1%
H
4.8
6.3
|
L
 32.6%
H
4.3
6.3
|
L
 43.9%
H
3.6
6.3
|
L
 129.6%
H
2.2
6.3
|
L
 14.6%
H
2.2
11.7
|
L
 -40.0%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
371.1
|
9.1
|
L
 2.0%
H
8.9
9.2
|
L
 -1.9%
H
8.6
9.3
|
L
 -10.5%
H
8.6
10.7
|
L
 -2.2%
H
8.6
12.6
|
L
 -38.9%
H
8.6
17.0
|
L
 -31.0%
H
8.6
20.7
|
L
 -77.3%
H
8.6
41.1
|
L
 -79.0%
H
8.6
74.4
|
| Outset Medical Inc |
|
59.2
|
3.2
|
L
 -1.9%
H
3.2
3.3
|
L
 -12.3%
H
3.2
3.6
|
L
 -25.9%
H
3.2
4.7
|
L
 -29.8%
H
3.2
5.5
|
L
 -77.0%
H
3
16.2
|
L
 -98.4%
H
0.5
198
|
L
 -99.6%
H
0.5
905.0
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
193.0
|
1.5
|
L
 0.7%
H
1.5
1.5
|
L
 -12.3%
H
1.5
1.7
|
L
 -14.8%
H
1.5
2.0
|
L
 -35.9%
H
1.5
2.7
|
L
 -69.6%
H
1.5
7.1
|
L
 -42.3%
H
1.5
7.1
|
L
 -90.2%
H
1.5
17.1
|
L
H
1.5
310.9
|
| Orasure Tech Inc |
|
232.4
|
3.4
|
L
 3.7%
H
3.2
3.4
|
L
 -3.2%
H
3.1
3.5
|
L
 -16.2%
H
3.1
4.0
|
L
 -19.4%
H
3.1
4.6
|
L
 1.8%
H
2.1
4.6
|
L
 -41.0%
H
2.1
8.5
|
L
 -69.0%
H
2.1
13.6
|
L
 -60.7%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
419.6
|
1.4
|
L
 3.9%
H
1.3
1.4
|
L
H
1.3
1.4
|
L
 17.4%
H
1.1
1.6
|
L
 3.1%
H
1.1
1.8
|
L
 15.4%
H
1.1
2.7
|
L
 -88.5%
H
0.9
11.9
|
L
 -95.3%
H
0.9
31.1
|
L
 -83.8%
H
0.9
53.7
|
| PAVmed Inc |
|
43.2
|
4.4
|
L
 5.0%
H
4.1
4.6
|
L
 -16.9%
H
4.1
5.4
|
L
 -7.4%
H
4.1
5.7
|
L
 -12.2%
H
3.9
6.7
|
L
 -65.2%
H
3.9
28.4
|
L
 -97.2%
H
3.9
171
|
L
 -99.9%
H
3.9
4365
|
L
 -99.9%
H
3.9
6502.5
|
| Pro-Dex Inc (co) |
|
213.2
|
66.6
|
L
 6.0%
H
62.6
69.1
|
L
 -9.3%
H
58.0
74.0
|
L
 -2.0%
H
58.0
77
|
L
 7.0%
H
53
77
|
L
 101.3%
H
23.5
77
|
L
 301.0%
H
14.5
77
|
L
 166.2%
H
12.4
77
|
L
 1177.5%
H
3.8
77
|
| Pulse Biosciences Inc |
|
3,866.4
|
54.2
|
L
 2.1%
H
51.6
55.8
|
L
 1.8%
H
47.7
58.9
|
L
 20.7%
H
42.7
58.9
|
L
 122.5%
H
24.4
58.9
|
L
 273.4%
H
12.6
58.9
|
L
 1088.8%
H
3.8
58.9
|
L
 161.3%
H
1.2
58.9
|
L
 743.1%
H
1.2
58.9
|
| Axe Compute Inc |
|
124.7
|
10.8
|
L
 -3.7%
H
10.7
11.8
|
L
 0.8%
H
10.5
12
|
L
 28.9%
H
7.4
12
|
L
 51.3%
H
5.9
12
|
L
 -24.5%
H
1.0
32.1
|
L
 -78.7%
H
1.0
61.4
|
L
 -96.6%
H
1.0
439.8
|
L
 -99.9%
H
1.0
18150
|
| Precision Optics Corp Inc |
|
47.5
|
4.3
|
L
 -0.5%
H
4.3
4.5
|
L
 -0.2%
H
4.3
4.5
|
L
 3.3%
H
4.2
5.0
|
L
 -26.3%
H
4.1
6.2
|
L
 -1.4%
H
3.6
6.2
|
L
 -26.6%
H
3.5
6.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
9,557.0
|
137.8
|
L
 4.4%
H
131.6
138.0
|
L
 -6.6%
H
131.2
147.4
|
L
 -5.9%
H
131.2
155.2
|
L
 -8.0%
H
126.4
172.9
|
L
 -59.7%
H
126.4
354.9
|
L
 -22.1%
H
125.8
354.9
|
L
 -53.3%
H
125.8
354.9
|
L
 238.7%
H
30.7
354.9
|
| Procept BioRobotics Corp |
|
1,203.9
|
21.0
|
L
 3.1%
H
20.6
21.5
|
L
 -7.6%
H
19.6
22.6
|
L
 -4.2%
H
19.6
22.8
|
L
 -18.2%
H
16.7
25.5
|
L
 -43.4%
H
16.7
40.1
|
L
 -37.7%
H
16.7
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
| Profound Medical Corp |
|
212.3
|
5.8
|
L
 -2.7%
H
5.8
6.0
|
L
 -15.7%
H
5.5
6.9
|
L
 -12.9%
H
5.5
7.4
|
L
 -12.2%
H
5.5
8.5
|
L
 43.8%
H
3.9
9.0
|
L
 -30.3%
H
3.8
11.7
|
L
 -59.3%
H
3.1
16.2
|
L
 -44.7%
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
762.6
|
11.1
|
L
 -5.6%
H
11.0
12.0
|
L
 -20.4%
H
11.0
14
|
L
 -26.3%
H
11.0
15.5
|
L
 -21.3%
H
11.0
19.8
|
L
 -61.1%
H
9.9
35.6
|
L
 -85.4%
H
9.9
77.4
|
L
 -92.2%
H
9.9
180.1
|
L
 -46.2%
H
9.9
306.7
|
| Quanterix Corp |
|
118.2
|
2.5
|
L
 -2.3%
H
2.4
2.7
|
L
 -7.1%
H
2.4
2.8
|
L
 -12.6%
H
2.4
3.3
|
L
 -19.4%
H
2.2
4.6
|
L
 -48.0%
H
2.2
8.8
|
L
 -90.3%
H
2.2
29.7
|
L
 -94.6%
H
2.2
60.9
|
L
H
2.2
92.6
|
| AVITA Medical Inc |
|
315.1
|
10.2
|
L
 3.1%
H
9.8
10.5
|
L
 -9.0%
H
9.6
11.2
|
L
 27.2%
H
7.7
11.4
|
L
 160.6%
H
3.7
11.4
|
L
 123.5%
H
3.2
11.4
|
L
 -35.1%
H
3.2
18.9
|
L
 -45.9%
H
3.2
21.7
|
L
 42.5%
H
3.2
55.4
|
| Rosecliff Acq Corp I (Class A) |
|
-
|
1.6
|
L
 0.6%
H
1.6
1.6
|
L
 2.6%
H
1.5
1.7
|
L
 -6.9%
H
1.5
1.8
|
L
 -11.5%
H
1.5
1.9
|
L
 -17.0%
H
1.2
3.0
|
L
 -66.5%
H
1.2
4.7
|
L
 -83.4%
H
1.2
19.5
|
L
H
1.2
19.5
|
| Rockwell Medical Inc |
|
31.4
|
7.8
|
L
 -2.3%
H
7.8
8.0
|
L
 -2.5%
H
7.3
8.3
|
L
 -0.5%
H
7.0
8.5
|
L
 24.5%
H
4.9
8.5
|
L
 -52.0%
H
4.9
17.2
|
L
 -63.5%
H
4.9
51.5
|
L
 -88.7%
H
4.9
73.4
|
L
 -99.0%
H
4.9
987.8
|
| Vyome Holdings Inc |
|
14.5
|
2.1
|
L
H
2.1
2.1
|
L
 -7.2%
H
2.1
2.2
|
L
 -4.6%
H
2.1
2.4
|
L
 -10.4%
H
2.0
2.4
|
L
 -71.8%
H
1.8
9.6
|
L
 -95.3%
H
0.3
48.4
|
L
 -100.0%
H
0.3
9773
|
L
H
0.3
1381560
|
| Rewalk Robotics Ltd |
|
427.4
|
7.1
|
L
 -0.1%
H
6.9
7.3
|
L
 1.9%
H
6.9
7.4
|
L
 -10%
H
6.9
8.0
|
L
 4.9%
H
6.8
9.6
|
L
 1125.9%
H
0.4
9.6
|
L
 21.1%
H
0.4
9.6
|
L
 -21.3%
H
0.4
19.5
|
L
 -99.3%
H
0.4
1137.5
|
| Sight Sciences Inc |
|
447.9
|
8.1
|
L
 -0.1%
H
8.1
8.2
|
L
 -2.6%
H
7.7
8.4
|
L
 -2.3%
H
7.7
8.9
|
L
 58.5%
H
4.4
8.9
|
L
 135.0%
H
3.2
9.2
|
L
 146.4%
H
1.0
9.2
|
L
 -72.6%
H
1.0
30.5
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
5,285.1
|
18.5
|
L
 0.8%
H
18.4
18.6
|
L
 -2.0%
H
18.0
19.1
|
L
 -2.6%
H
18.0
19.7
|
L
 14.4%
H
15.4
19.8
|
L
 15.4%
H
13.1
19.9
|
L
 24.1%
H
9.5
19.9
|
L
 -25.7%
H
5.8
27.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
838.1
|
18.7
|
L
 1.7%
H
18.3
18.8
|
L
 1.1%
H
18.0
19.2
|
L
 -1.3%
H
18.0
20.3
|
L
 21.3%
H
14.9
20.3
|
L
 19.1%
H
11.5
21.9
|
L
 -17.6%
H
11.5
23.1
|
L
 -16.9%
H
11.1
29.5
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
11.9
|
1.8
|
L
 -0.6%
H
1.7
1.8
|
L
 9.8%
H
1.6
1.9
|
L
 4.7%
H
1.5
1.9
|
L
 -15.6%
H
1.4
2.2
|
L
 -58.9%
H
1.4
5.1
|
L
 -99.1%
H
0.1
208
|
L
 -100.0%
H
0.1
28200
|
L
 -100.0%
H
0.1
8136000
|
| Beauty Health Co (Class A) |
|
91.1
|
0.7
|
L
H
0.7
0.7
|
L
 2.9%
H
0.7
0.8
|
L
 6.1%
H
0.6
0.8
|
L
 7.7%
H
0.6
1.2
|
L
 -72.3%
H
0.6
2.7
|
L
 -89.5%
H
0.6
6.9
|
L
 -97.3%
H
0.6
30.2
|
L
H
0.6
30.2
|
| Sanara MedTech Inc |
|
321.4
|
35.0
|
L
 0.2%
H
34.8
35.1
|
L
 0.7%
H
34.7
35.2
|
L
 2.4%
H
34.0
35.2
|
L
 68.1%
H
20.4
35.2
|
L
 3%
H
16.1
35.7
|
L
 -1.7%
H
16.1
43.3
|
L
 5.9%
H
16.1
50.2
|
L
 732.9%
H
2
75
|
| Sensus Healthcare Inc |
|
51.5
|
3.1
|
L
 -0.6%
H
3.1
3.2
|
L
 -1.9%
H
3.1
3.4
|
L
 -1.0%
H
2.8
3.7
|
L
 15.5%
H
2.7
3.7
|
L
 -1.6%
H
2.7
5.5
|
L
 15.9%
H
1.8
9.3
|
L
 -11.8%
H
1.8
15.3
|
L
 -48.9%
H
1.8
15.3
|
| Staar Surgical Co. |
|
1,156.8
|
23.1
|
L
 1.8%
H
22.2
23.2
|
L
 -1.7%
H
22.1
24.4
|
L
 -8.9%
H
21.8
26.2
|
L
 -18.7%
H
21.2
31.3
|
L
 -16.7%
H
15.6
35.9
|
L
 -47.5%
H
13.5
52.7
|
L
 -83.3%
H
13.5
148.0
|
L
 168.3%
H
7.5
163.1
|
| Neuronetics Inc |
|
221.0
|
2.9
|
L
 -4.3%
H
2.9
3.3
|
L
 0.7%
H
2.8
3.3
|
L
 -4.3%
H
2.7
3.4
|
L
 118.1%
H
1.2
3.4
|
L
 -7.1%
H
0.8
3.4
|
L
 98.6%
H
0.5
5.9
|
L
 -57.4%
H
0.5
7.0
|
L
H
0.5
39.4
|
| SkyAI Inc |
|
61.4
|
1.4
|
L
 2.9%
H
1.3
1.4
|
L
 2.9%
H
1.2
1.4
|
L
 42%
H
1.0
1.6
|
L
 26.8%
H
0.9
1.6
|
L
 -84.4%
H
0.9
9.4
|
L
 -100.0%
H
0.0
5874
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
511.3
|
22.6
|
L
 0.8%
H
22.3
23
|
L
 3.2%
H
21.3
23
|
L
 -4.8%
H
21.3
24.9
|
L
 -14.2%
H
21.3
32.4
|
L
 67.1%
H
13.4
37.8
|
L
 28.2%
H
8.6
37.8
|
L
 -46.3%
H
6.3
46.4
|
L
 36.4%
H
6.3
76.6
|
| TELA Bio Inc |
|
46.7
|
1.0
|
L
 7.2%
H
0.9
1.0
|
L
 26.8%
H
0.8
1.0
|
L
 52.9%
H
0.6
1.0
|
L
 20.9%
H
0.6
1.0
|
L
 -34.2%
H
0.5
1.7
|
L
 -88.3%
H
0.5
9
|
L
 -91.5%
H
0.5
14
|
L
H
0.5
23.5
|
| Valion Bio Inc |
|
1.9
|
2.1
|
L
 -7.1%
H
2.1
2.4
|
L
 -24.2%
H
2.1
2.7
|
L
 -50.9%
H
2.1
7.3
|
L
 -85.2%
H
2.1
32.5
|
L
 -97.3%
H
2.1
80.2
|
L
 -99.8%
H
2.1
1364.2
|
L
H
2.1
276250
|
L
H
2.1
276250
|
| Treace Medical Concepts Inc |
|
301.1
|
4.6
|
L
 2.7%
H
4.4
4.7
|
L
 -3.7%
H
4.3
4.9
|
L
 2.7%
H
4.3
5.0
|
L
 14.0%
H
3.8
5.2
|
L
 -35.9%
H
1.2
7.6
|
L
 -70.2%
H
1.2
16.0
|
L
 -83.3%
H
1.2
31.0
|
L
H
1.2
37.2
|
| Transmedics Grp Inc |
|
2,977.2
|
85.9
|
L
 4.5%
H
80.6
88.5
|
L
 -4.6%
H
79.2
89.6
|
L
 -4.2%
H
79.2
95.2
|
L
 17.8%
H
64.8
95.2
|
L
 -25.1%
H
60.1
156
|
L
 45.5%
H
36.4
177.4
|
L
 178.3%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,169.6
|
16.8
|
L
 -1.8%
H
16.6
17.6
|
L
 -15.5%
H
16.6
20.6
|
L
 -27.3%
H
16.6
24.8
|
L
 1.3%
H
14.0
24.8
|
L
 37%
H
11.5
29.7
|
L
 -29.3%
H
10.0
53.7
|
L
 -86.0%
H
10.0
155.9
|
L
 -76.5%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
6.1
|
7.5
|
L
 -3.5%
H
7.3
7.6
|
L
 -20.6%
H
6.9
9.7
|
L
 -37.1%
H
6.9
13.2
|
L
 -61.7%
H
6.9
22.2
|
L
 -79.1%
H
6.9
52.5
|
L
 -99.9%
H
6.9
15675
|
L
 -100.0%
H
6.9
46875
|
L
 -100.0%
H
6.9
252562.5
|
| Utah Medical Products Inc |
|
225.0
|
70.7
|
L
 1.4%
H
69.5
71.3
|
L
 -0.6%
H
68.5
71.3
|
L
 -2.0%
H
68.5
73.5
|
L
 4.2%
H
63.8
75.8
|
L
 13.4%
H
53.7
75.8
|
L
 -17.2%
H
51.3
89.2
|
L
 -21.6%
H
51.3
133.9
|
L
 13.3%
H
51.3
133.9
|
| Vivani Medical Inc |
|
113.7
|
1.3
|
L
 -0.8%
H
1.2
1.3
|
L
 -15.4%
H
1.2
1.5
|
L
 -6.0%
H
1.2
1.5
|
L
 14.6%
H
1.1
1.7
|
L
 4.1%
H
0.9
1.9
|
L
 35.5%
H
0.8
7.8
|
L
 -87.9%
H
0.8
10.8
|
L
 -98.4%
H
0.8
86.4
|
| Veracyte Inc |
|
3,312.9
|
41.2
|
L
 0.8%
H
40.5
41.4
|
L
 -3.1%
H
40.5
44.2
|
L
 -3.3%
H
40.1
46.0
|
L
 -12.9%
H
40.1
60.9
|
L
 33.5%
H
29.5
60.9
|
L
 62.6%
H
18.6
60.9
|
L
 -14.6%
H
14.9
60.9
|
L
 507.8%
H
5.2
86.0
|
| Varex Imaging Corp |
|
778.1
|
18.5
|
L
H
18.5
18.5
|
L
 -0.3%
H
18.5
18.5
|
L
 -0.2%
H
18.5
18.5
|
L
 67.2%
H
9.6
18.6
|
L
 63.4%
H
9.1
18.6
|
L
H
6.8
21.5
|
L
 -35.5%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
3.6
|
0.2
|
L
H
0.2
0.2
|
L
 -5.3%
H
0.2
0.2
|
L
 -40%
H
0.2
0.5
|
L
 -68.4%
H
0.2
0.6
|
L
 -94.8%
H
0.2
3.7
|
L
 -97.0%
H
0.2
48.8
|
L
 -99.9%
H
0.2
133.8
|
L
H
0.2
360.3
|
| Wrap Tech Inc |
|
101.9
|
1.7
|
L
 -1.8%
H
1.6
1.7
|
L
 -1.2%
H
1.6
1.7
|
L
 -5.2%
H
1.4
1.9
|
L
 26.0%
H
1.0
2.7
|
L
 -19.5%
H
1.0
3.2
|
L
H
1.0
7.0
|
L
 -75.5%
H
1.0
7.0
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
3.1
|
3.1
|
L
 -1.9%
H
3.1
3.3
|
L
 -11.1%
H
3.1
3.6
|
L
 -54.6%
H
3.1
7
|
L
 -57.7%
H
3.1
10.5
|
L
 -93.5%
H
3.1
55.6
|
L
 -99.7%
H
3.1
1286
|
L
 -99.9%
H
3.1
6564
|
L
H
3.1
18000
|
| DENTSPLY Sirona Inc |
|
2,069.3
|
10.4
|
L
 -0.8%
H
10.3
10.6
|
L
 -8.8%
H
10.3
11.3
|
L
 -10.4%
H
10.3
11.9
|
L
 2.9%
H
9.9
14.4
|
L
 -23.3%
H
9.4
14.8
|
L
 -71.0%
H
9.4
37.6
|
L
 -83.2%
H
9.4
63.1
|
L
 -82.5%
H
9.4
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
6.0
|
2.4
|
L
 -5.1%
H
2.4
2.5
|
L
 -4.0%
H
2.4
2.6
|
L
 -13.2%
H
2.3
3.5
|
L
 14.1%
H
2.2
3.5
|
L
 -88.8%
H
2.0
41.1
|
L
 -84.7%
H
2.0
79.8
|
L
 -96.6%
H
2.0
79.8
|
L
 -96.9%
H
2.0
107.0
|
| 111 Inc (ADR) |
|
30.8
|
3.5
|
L
 -2.5%
H
3.3
3.6
|
L
 1.2%
H
2.7
3.9
|
L
 -7.9%
H
2.7
4.1
|
L
 -28.4%
H
2.7
5
|
L
 -40.9%
H
2.5
11.2
|
L
 34.6%
H
0.4
11.3
|
L
 -49.6%
H
0.4
11.3
|
L
H
0.4
45.9
|
| Jin Medical Intl Ltd |
|
145.1
|
2.0
|
L
 -4.8%
H
1.9
2.1
|
L
 -5.3%
H
1.8
2.3
|
L
 -39.6%
H
1.8
3.7
|
L
 -18.6%
H
1.5
3.7
|
L
 -84.4%
H
1.5
13.5
|
L
 -82.4%
H
1.5
509.9
|
L
H
1.5
509.9
|
L
H
1.5
509.9
|
| HeartBeam Inc |
|
23.1
|
0.4
|
L
H
0.4
0.4
|
L
 -4.7%
H
0.4
0.5
|
L
 -30.5%
H
0.4
0.6
|
L
 -46.1%
H
0.4
0.8
|
L
 -71.1%
H
0.4
4
|
L
 -74.1%
H
0.4
4
|
L
 -74.1%
H
0.4
4
|
L
 -74.1%
H
0.4
4
|
| TriSalus Life Sciences Inc |
|
293.7
|
4.8
|
L
 2.4%
H
4.6
4.8
|
L
 -4.6%
H
4.5
5.0
|
L
 -15.3%
H
4.5
5.6
|
L
 26.5%
H
3.7
5.9
|
L
 7.7%
H
2.2
8.0
|
L
 2.4%
H
2.2
10.4
|
L
 -29.5%
H
2.2
10.4
|
L
 -29.5%
H
2.2
10.4
|
| Cencora |
|
62,253.5
|
326.2
|
L
 1.5%
H
322.5
327.8
|
L
 -1.4%
H
318.0
330
|
L
 5.4%
H
302.0
338.7
|
L
 15.8%
H
269.3
338.7
|
L
 7.8%
H
244.8
377.5
|
L
 84.6%
H
175.5
377.5
|
L
 163.9%
H
113.7
377.5
|
L
 282.7%
H
68.4
377.5
|
| Spectral AI Inc (Class A) |
|
51.8
|
1.6
|
L
 0.6%
H
1.6
1.6
|
L
 2.6%
H
1.5
1.7
|
L
 -6.9%
H
1.5
1.8
|
L
 -11.5%
H
1.5
1.9
|
L
 -17.0%
H
1.2
3.0
|
L
 -66.5%
H
0.8
4.7
|
L
H
0.8
13
|
L
H
0.8
13
|
| Envoy Medical Inc (Class A) |
|
56.5
|
0.7
|
L
 -1.4%
H
0.7
0.8
|
L
 2.8%
H
0.7
0.8
|
L
 -2.7%
H
0.7
0.8
|
L
 15.9%
H
0.6
0.9
|
L
 -43.4%
H
0.4
1.9
|
L
H
0.4
11.5
|
L
H
0.4
11.5
|
L
H
0.4
11.5
|
| Autonomix Medical Inc |
|
4.2
|
4.3
|
L
 -0.9%
H
4.2
4.4
|
L
 -5.7%
H
4.2
4.8
|
L
 -36.9%
H
4.2
10.0
|
L
 -46.6%
H
2.4
24.7
|
L
 -81.4%
H
2.4
32.6
|
L
H
2.4
3192
|
L
H
2.4
3192
|
L
H
2.4
3192
|
| Rewalk Robotics Ltd |
|
20.1
|
7.1
|
L
 -0.1%
H
6.9
7.3
|
L
 1.9%
H
6.9
7.4
|
L
 -10%
H
6.9
8.0
|
L
 4.9%
H
6.8
9.6
|
L
 1.3%
H
4.1
10.6
|
L
 -89.9%
H
4.1
109.2
|
L
 -93.4%
H
4.1
233.5
|
L
 -99.9%
H
4.1
13650
|
| GRAIL Inc |
|
3,373.6
|
75.5
|
L
 -0.9%
H
73.5
76.6
|
L
 -6.0%
H
73.5
81.7
|
L
 10.7%
H
66.4
85.5
|
L
 26.2%
H
57.1
85.5
|
L
 98.6%
H
37.0
118.8
|
L
H
12.6
118.8
|
L
H
12.6
118.8
|
L
H
12.6
118.8
|
| Work Medical Tech Grp Ltd |
|
8.6
|
1.9
|
L
 2.1%
H
1.9
1.9
|
L
 -8.6%
H
1.9
2.2
|
L
 -8.1%
H
1.9
3.2
|
L
 -74.4%
H
1.8
12
|
L
 -100%
H
1.8
930000
|
L
H
1.8
8446000
|
L
H
1.8
8446000
|
L
H
1.8
8446000
|
| iTonic Holdings Ordinary |
|
4.9
|
0.3
|
L
 -3.3%
H
0.3
0.3
|
L
 -9.4%
H
0.3
0.3
|
L
H
0.2
0.4
|
L
 -14.7%
H
0.2
0.4
|
L
 -65.9%
H
0.2
1.2
|
L
H
0.2
32
|
L
H
0.2
32
|
L
H
0.2
32
|
| Ceribell Inc |
|
933.7
|
24.3
|
L
 3.0%
H
23.6
24.6
|
L
 -1.6%
H
23.0
24.7
|
L
 4.7%
H
23.0
25.3
|
L
 31.7%
H
16.0
25.3
|
L
 110.3%
H
10.9
25.3
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
849.8
|
8.7
|
L
 4.4%
H
8.3
8.7
|
L
 -3.5%
H
8.1
9.0
|
L
 -2.4%
H
8.1
10.1
|
L
 -4.7%
H
7.7
11.1
|
L
 56.6%
H
3.3
11.1
|
L
H
2.3
11.1
|
L
H
2.3
11.1
|
L
H
2.3
11.1
|
| Beta Bionics Inc |
|
752.7
|
16.7
|
L
 1.0%
H
15.5
17.6
|
L
 -13.9%
H
15.5
19.5
|
L
 -7.5%
H
15.5
20.7
|
L
 15.1%
H
12.7
20.7
|
L
 -36.7%
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
| DataMEDS AI Inc |
|
2.6
|
0.9
|
L
 -4.4%
H
0.9
0.9
|
L
 -6.5%
H
0.9
1.0
|
L
 -42.3%
H
0.8
1.7
|
L
 -75.3%
H
0.8
3.9
|
L
 -98.9%
H
0.8
75
|
L
H
0.8
352
|
L
H
0.8
352
|
L
H
0.8
352
|
| Anbio biotech (Class A) |
|
268.2
|
6.1
|
L
 -3.6%
H
6.1
6.4
|
L
 -6.6%
H
6.1
6.8
|
L
 -40.5%
H
6.1
13.8
|
L
 -60.8%
H
6.1
18
|
L
 -85.9%
H
6.1
51.3
|
L
H
5.2
55.7
|
L
H
5.2
55.7
|
L
H
5.2
55.7
|
| Kestra Medical Tech Ltd |
|
1,410.0
|
24.1
|
L
 5.3%
H
22.8
24.4
|
L
 -5.8%
H
22.4
25.8
|
L
 -13.3%
H
22.4
28.9
|
L
 15.4%
H
18.5
28.9
|
L
 10.2%
H
17.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
36.6
|
4.3
|
L
 3.7%
H
4.1
4.4
|
L
 -3.0%
H
3.9
4.5
|
L
 -10.9%
H
3.9
5.2
|
L
 -71.5%
H
3.9
15.4
|
L
 -88.5%
H
3.9
40.9
|
L
 -86.8%
H
3.9
46.6
|
L
 -86.8%
H
3.9
46.6
|
L
 -86.8%
H
3.9
46.6
|
| SS Innovations Intl Inc |
|
677.3
|
3.4
|
L
 2.1%
H
3.3
3.5
|
L
 -0.9%
H
3.2
3.5
|
L
 -11.8%
H
3.2
4
|
L
 0.6%
H
3.2
4.2
|
L
 -41.7%
H
3.1
10
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
| CapsoVision Inc |
|
325.8
|
6.5
|
L
 -1.4%
H
6.5
6.9
|
L
 8.7%
H
6.0
7.0
|
L
 -4.1%
H
5.8
7.0
|
L
 -9.5%
H
5.6
7.8
|
L
 58.0%
H
4.1
15.4
|
L
 86%
H
3.4
15.4
|
L
 86%
H
3.4
15.4
|
L
 86%
H
3.4
15.4
|
| Pomdoctor ADR |
|
6.6
|
0.7
|
L
 -2.7%
H
0.6
0.8
|
L
 -14.5%
H
0.6
0.8
|
L
 -30.4%
H
0.6
1.2
|
L
 -61.4%
H
0.5
2.0
|
L
 -99.0%
H
0.5
115.7
|
L
 -99.0%
H
0.5
115.7
|
L
 -99.0%
H
0.5
115.7
|
L
 -99.0%
H
0.5
115.7
|
| Medline Inc Ordinary Shares |
|
28,592.9
|
32.6
|
L
 0.2%
H
32.1
32.9
|
L
 -10.9%
H
31.9
36.8
|
L
 -8.4%
H
31.9
37.0
|
L
 -11.0%
H
31.9
43.6
|
L
 -20.5%
H
31.9
50.9
|
L
 -20.5%
H
31.9
50.9
|
L
 -20.5%
H
31.9
50.9
|
L
 -20.5%
H
31.9
50.9
|
| MiniMed Group Inc |
|
6,181.3
|
22.0
|
L
 -2.4%
H
21.3
22.7
|
L
 -5.6%
H
21.3
23.7
|
L
 9.7%
H
18.9
24.4
|
L
 44.9%
H
13.7
24.4
|
L
H
10.7
24.4
|
L
H
10.7
24.4
|
L
H
10.7
24.4
|
L
H
10.7
24.4
|
| Mobia Medical Inc |
|
333.9
|
10.0
|
L
 0.2%
H
9.9
10.4
|
L
 -13.8%
H
9.9
11.8
|
L
 -14.1%
H
9.9
12.7
|
L
 -18.5%
H
9.9
15.3
|
L
 -14.6%
H
9.9
15.3
|
L
 -14.6%
H
9.9
15.3
|
L
 -14.6%
H
9.9
15.3
|
L
 -14.6%
H
9.9
15.3
|
| FocalTherics ADR |
|
188.9
|
4.1
|
L
 0.2%
H
4.0
4.1
|
L
 -1.0%
H
4.0
4.3
|
L
 -11.2%
H
4.0
4.8
|
L
 -12.9%
H
4.0
6.4
|
L
 -9.9%
H
4.0
6.4
|
L
 -9.9%
H
4.0
6.4
|
L
 -9.9%
H
4.0
6.4
|
L
 -9.9%
H
4.0
6.4
|